Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway

Lung cancer is the leading cause of death in individuals with malignant disease. Non‐small‐cell lung cancer (NSCLC) is the most common type of lung cancer, and chemotherapy drugs such as cisplatin are the most widely used treatment for this disease. Baicalein is a purified flavonoid compound that ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chunya, Wang, Huaqi, Chen, Shanshan, Yang, Rui, Li, Hui, Zhang, Guojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867147/
https://www.ncbi.nlm.nih.gov/pubmed/29392841
http://dx.doi.org/10.1111/jcmm.13556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867147/
https://www.ncbi.nlm.nih.gov/pubmed/29392841
http://dx.doi.org/10.1111/jcmm.13556

Ejemplares similares